Works matching AU Onozawa, Yusuke

Results: 90
    1

    Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

    Published in:
    2017
    By:
    • Sadayuki Kawai;
    • Tomoya Yokota;
    • Yusuke Onozawa;
    • Satoshi Hamauchi;
    • Akira Fukutomi;
    • Hirofumi Ogawa;
    • Tsuyoshi Onoe;
    • Tetsuro Onitsuka;
    • Takashi Yurikusa;
    • Akiko Todaka;
    • Takahiro Tsushima;
    • Yukio Yoshida;
    • Yosuke Kito;
    • Keita Mori;
    • Hirofumi Yasui;
    • Kawai, Sadayuki;
    • Yokota, Tomoya;
    • Onozawa, Yusuke;
    • Hamauchi, Satoshi;
    • Fukutomi, Akira
    Publication type:
    journal article
    2

    Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.

    Published in:
    Oncology, 2017, v. 93, n. 5, p. 329, doi. 10.1159/000479280
    By:
    • Komori, azusa;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi;
    • Masuishi, Toshiki;
    • Kito, Yosuke;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Ishihara, Makoto;
    • Todaka, akiko;
    • Tanaka, Tsutomu;
    • Yokota, Tomoya;
    • Kadowaki, Shigenori;
    • Machida, Nozomu;
    • Ura, Takashi;
    • Fukutomi, akira;
    • ando, Masashi;
    • Onozawa, Yusuke;
    • Tajika, Masahiro;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    3
    4
    5

    Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.

    Published in:
    Oncologist, 2023, v. 28, n. 11, p. e1108, doi. 10.1093/oncolo/oyad143
    By:
    • Taniguchi, Hiroya;
    • Yamazaki, Kentaro;
    • Masuishi, Toshiki;
    • Kawakami, Takeshi;
    • Onozawa, Yusuke;
    • Honda, Kazunori;
    • Kadowaki, Shigenori;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Hamauchi, Satoshi;
    • Todaka, Akiko;
    • Yokota, Tomoya;
    • Ando, Masashi;
    • Mori, Keita;
    • Shirasu, Hiromichi;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    6
    7
    8

    Treatable Subsets in Cancer of Unknown Primary Origin.

    Published in:
    Cancer Science, 2001, v. 92, n. 6, p. 704, doi. 10.1111/j.1349-7006.2001.tb01151.x
    By:
    • Sumi, Hajime;
    • Itoh, Kuniaki;
    • Onozawa, Yusuke;
    • Shigeoka, Yasushi;
    • Kodama, Keiji;
    • Ishizawa, Kenichi;
    • Fujii, Hirofumi;
    • Minami, Hironobu;
    • Igarashi, Tadahiko;
    • Sasaki, Yasutsuna
    Publication type:
    Article
    9

    Radiation-induced xerostomia and cariogenic dietary habits.

    Published in:
    Supportive Care in Cancer, 2024, v. 32, n. 2, p. 1, doi. 10.1007/s00520-023-08298-x
    By:
    • Kawashima, Miho;
    • Kawabata, Takanori;
    • Ando, Chikako;
    • Sakuma, Megumi;
    • Aoyama, Takashi;
    • Ogawa, Hirofumi;
    • Yokota, Tomoya;
    • Onozawa, Yusuke;
    • Mukaigawa, Takashi;
    • Nishimura, Tetsuo;
    • Mori, Keita;
    • Yurikusa, Takashi
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 11, p. 1914, doi. 10.1007/s10147-020-01742-6
    By:
    • Shirasu, Hiromichi;
    • Yokota, Tomoya;
    • Kawakami, Takeshi;
    • Hamauchi, Satoshi;
    • Onozawa, Yusuke;
    • Ogawa, Hirofumi;
    • Onoe, Tsuyoshi;
    • Mori, Keita;
    • Onitsuka, Tetsuro
    Publication type:
    Article
    21

    Chemoradiotherapy for high-risk stage II laryngeal cancer.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1596, doi. 10.1007/s10147-020-01705-x
    By:
    • Hamauchi, Satoshi;
    • Yokota, Tomoya;
    • Onozawa, Yusuke;
    • Ogawa, Hirofumi;
    • Onoe, Tsuyoshi;
    • Kamijo, Tomoyuki;
    • Iida, Yoshiyuki;
    • Onitsuka, Tetsuro;
    • Yasui, Hirofumi
    Publication type:
    Article
    22

    Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 258, doi. 10.1007/s10147-019-01560-5
    By:
    • Kimura, Hidenori;
    • Hamauchi, Satoshi;
    • Kawai, Sadayuki;
    • Onozawa, Yusuke;
    • Yasui, Hirofumi;
    • Yamashita, Aiko;
    • Ogawa, Hirofumi;
    • Onoe, Tsuyoshi;
    • Kamijo, Tomoyuki;
    • Iida, Yoshiyuki;
    • Onitsuka, Tetsuro;
    • Yokota, Tomoya
    Publication type:
    Article
    23

    Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 468, doi. 10.1007/s10147-018-01392-9
    By:
    • Hamauchi, Satoshi;
    • Yokota, Tomoya;
    • Mizumachi, Takatsugu;
    • Onozawa, Yusuke;
    • Ogawa, Hirofumi;
    • Onoe, Tsuyoshi;
    • Kamijo, Tomoyuki;
    • Iida, Yoshiyuki;
    • Nishimura, Tetsuo;
    • Onitsuka, Tetsuro;
    • Yasui, Hirofumi;
    • Homma, Akihiro
    Publication type:
    Article
    24

    Phase II study of S-1 plus oxaliplatin 130 mg/m<sup>2</sup> in Japanese patients with advanced gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1084, doi. 10.1007/s10147-018-1308-1
    By:
    • Kito, Yosuke;
    • Machida, Nozomu;
    • Kawai, Sadayuki;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Yokota, Tomoya;
    • Yamazaki, Kentaro;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Tsuji, Kunihiro;
    • Doyama, Hisashi;
    • Haraguchi, Yutaka;
    • Nakashima, Koji;
    • Kunieda, Kenji;
    • Taku, Keisei;
    • Mori, Keita;
    • Yasui, Hirofumi
    Publication type:
    Article
    25

    Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1189, doi. 10.1007/s10147-018-1306-3
    By:
    • Kawahira, Masahiro;
    • Yokota, Tomoya;
    • Hamauchi, Satoshi;
    • Kawai, Sadayuki;
    • Yoshida, Yukio;
    • Onozawa, Yusuke;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Machida, Nozomu;
    • Yamazaki, Kentaro;
    • Fukutomi, Akira;
    • Yasui, Hirofumi
    Publication type:
    Article
    26

    Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.

    Published in:
    International Journal of Clinical Oncology, 2016, v. 21, n. 1, p. 1, doi. 10.1007/s10147-015-0852-1
    By:
    • Takeuchi, Hideki;
    • Saeki, Toshiaki;
    • Aiba, Keisuke;
    • Tamura, Kazuo;
    • Aogi, Kenjiro;
    • Eguchi, Kenji;
    • Okita, Kenji;
    • Kagami, Yoshikazu;
    • Tanaka, Ryuhei;
    • Nakagawa, Kazuhiko;
    • Fujii, Hirofumi;
    • Boku, Narikazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Udagawa, Yasuhiro;
    • Okawa, Yutaka;
    • Onozawa, Yusuke;
    • Sasaki, Hidenori;
    • Shima, Yasuo;
    • Shimoyama, Naohito
    Publication type:
    Article
    27

    Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2015, v. 20, n. 5, p. 1026, doi. 10.1007/s10147-015-0820-9
    By:
    • Nozawa, Masahiro;
    • Mukai, Hirofumi;
    • Takahashi, Shunji;
    • Uemura, Hiroji;
    • Kosaka, Takeo;
    • Onozawa, Yusuke;
    • Miyazaki, Jun;
    • Suzuki, Kazuhiro;
    • Okihara, Koji;
    • Arai, Yoichi;
    • Kamba, Tomomi;
    • Kato, Masashi;
    • Nakai, Yasutomo;
    • Furuse, Hiroshi;
    • Kume, Haruki;
    • Ide, Hisamitsu;
    • Kitamura, Hiroshi;
    • Yokomizo, Akira;
    • Kimura, Takahiro;
    • Tomita, Yoshihiko
    Publication type:
    Article
    28

    Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.

    Published in:
    International Journal of Clinical Oncology, 2015, v. 20, n. 3, p. 455, doi. 10.1007/s10147-014-0749-4
    By:
    • Izawa, Naoki;
    • Onozawa, Yusuke;
    • Hikosaka, Tomomi;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Machida, Nozomu;
    • Haraguchi, Yutaka;
    • Ogawa, Hirofumi;
    • Nishimura, Tetsuo;
    • Nakagawa, Masahiro;
    • Fuke, Tomohito;
    • Iida, Yoshiyuki;
    • Kamijo, Tomoyuki;
    • Onitsuka, Tetsuro;
    • Boku, Narikazu;
    • Yasui, Hirofumi;
    • Yokota, Tomoya
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Leptomeningeal carcinomatosis associated with gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 4, p. 361, doi. 10.1007/s10147-011-0301-8
    By:
    • Tomita, Hideharu;
    • Yasui, Hirofumi;
    • Boku, Narikazu;
    • Nakasu, Yoko;
    • Mitsuya, Koichi;
    • Onozawa, Yusuke;
    • Fukutomi, Akira;
    • Yamazaki, Kentaro;
    • Machida, Nozomu;
    • Taku, Keisei;
    • Todaka, Akiko;
    • Taniguchi, Hiroya;
    • Tsushima, Takahiro
    Publication type:
    Article
    35

    Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta.

    Published in:
    International Journal of Clinical Oncology, 2011, v. 16, n. 4, p. 359, doi. 10.1007/s10147-011-0192-8
    By:
    • Taniguchi, Hiroya;
    • Yamazaki, Kentaro;
    • Boku, Narikazu;
    • Funakoshi, Taro;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Sakamoto, Takeshi;
    • Tomita, Hideharu;
    • Machida, Nozomu;
    • Taku, Keisei;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Tsubosa, Yasuhiro;
    • Sato, Hiroshi;
    • Nishimura, Tetsuo;
    • Yasui, Hirofumi
    Publication type:
    Article
    36

    Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.

    Published in:
    International Journal of Clinical Oncology, 2010, v. 15, n. 3, p. 287, doi. 10.1007/s10147-010-0054-9
    By:
    • Sakamoto, Takeshi;
    • Yasui, Hirofumi;
    • Boku, Narikazu;
    • Onozawa, Yusuke;
    • Hironaka, Shuichi;
    • Fukutomi, Akira;
    • Yamazaki, Kentaro;
    • Taku, Keisei;
    • Machida, Nozomu;
    • Todaka, Akiko;
    • Tomita, Hideharu;
    • Tsushima, Takahiro;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi
    Publication type:
    Article
    37
    38

    A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.

    Published in:
    International Journal of Clinical Oncology, 2008, v. 13, n. 2, p. 150, doi. 10.1007/s10147-007-0738-y
    By:
    • Yamazaki, Kentaro;
    • Hironaka, Shuichi;
    • Boku, Narikazu;
    • Yasui, Hirofumi;
    • Fukutomi, Akira;
    • Yoshino, Takayuki;
    • Onozawa, Yusuke;
    • Hasuike, Noriaki;
    • Inui, Tetsuya;
    • Yamaguchi, Yuichiro;
    • Ono, Hiroyuki
    Publication type:
    Article
    39
    40

    Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.

    Published in:
    Journal of Gastroenterology, 2008, v. 43, n. 11, p. 875, doi. 10.1007/s00535-008-2236-z
    By:
    • Taira, Koichi;
    • Boku, Narikazu;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Hironaka, Shuichi;
    • Yoshino, Takayuki;
    • Yasui, Hirofumi;
    • Yamazaki, Kentaro;
    • Taku, Keisei;
    • Hashimoto, Takayuki;
    • Nishimura, Tetsuo
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.

    Published in:
    Investigational New Drugs, 2024, v. 42, n. 6, p. 655, doi. 10.1007/s10637-024-01480-w
    By:
    • Hamauchi, Satoshi;
    • Yasui, Hirofumi;
    • Yokota, Tomoya;
    • Tsushima, Takahiro;
    • Fushiki, Kunihiro;
    • Naito, Tateaki;
    • Ono, Akira;
    • Kado, Nobuhiro;
    • Onozawa, Yusuke;
    • Murakami, Haruyasu;
    • Takahashi, Toshiaki;
    • Hirashima, Yasuyuki;
    • Mori, Keita;
    • Yamazaki, Kentaro
    Publication type:
    Article
    47
    48
    49
    50